These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10331823)

  • 1. Itraconazole in cyclodextrin solution.
    Stevens DA
    Pharmacotherapy; 1999 May; 19(5):603-11. PubMed ID: 10331823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole.
    Taupitz T; Dressman JB; Buchanan CM; Klein S
    Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of itraconazole/2-hydroxypropyl-beta-cyclodextrin inclusion complex in aqueous propylene glycol solution.
    Miyake K; Irie T; Arima H; Hirayama F; Uekama K; Hirano M; Okamaoto Y
    Int J Pharm; 1999 Mar; 179(2):237-45. PubMed ID: 10053216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics.
    Willems L; van der Geest R; de Beule K
    J Clin Pharm Ther; 2001 Jun; 26(3):159-69. PubMed ID: 11422598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Displacement of itraconazole from cyclodextrin complexes in biorelevant media: In vitro evaluation of supersaturation and precipitation behavior.
    Stappaerts J; Augustijns P
    Int J Pharm; 2016 Sep; 511(1):680-687. PubMed ID: 27473276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations.
    Buchanan CM; Buchanan NL; Edgar KJ; Klein S; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF
    J Pharm Sci; 2007 Nov; 96(11):3100-16. PubMed ID: 17712849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of preparation method on itraconazole oral solutions using cyclodextrins as complexing agents.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Pharmazie; 2007 Jul; 62(7):510-4. PubMed ID: 17718191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal behavior of itraconazole in humans - Part 1: Supersaturation from a solid dispersion and a cyclodextrin-based solution.
    Brouwers J; Geboers S; Mols R; Tack J; Augustijns P
    Int J Pharm; 2017 Jun; 525(1):211-217. PubMed ID: 28414135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and cyclodextrin assisted dissolution rate enhancement of itraconazolium dinitrate salt.
    Kumar N; Shishu ; Bansal G; Kumar S; Jana AK
    Drug Dev Ind Pharm; 2013 Feb; 39(2):342-51. PubMed ID: 22553909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4, and 7.
    Peeters J; Neeskens P; Tollenaere JP; Van Remoortere P; Brewster ME
    J Pharm Sci; 2002 Jun; 91(6):1414-22. PubMed ID: 12115841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of β-cyclodextrin consolidated micellar dispersion for promoting the transcorneal permeation of a practically insoluble drug.
    Sayed S; Elsayed I; Ismail MM
    Int J Pharm; 2018 Oct; 549(1-2):249-260. PubMed ID: 30077759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nanosystem for water-insoluble drugs prepared by a new technology, nanoparticulation using a solid lipid and supercritical fluid.
    Park JW; Yun JM; Lee ES; Youn YS; Kim KS; Oh YT; Oh KT
    Arch Pharm Res; 2013 Nov; 36(11):1369-76. PubMed ID: 23780798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of itraconazole.
    De Beule K; Van Gestel J
    Drugs; 2001; 61 Suppl 1():27-37. PubMed ID: 11219548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of the cyclodextrin liquid preparation of itraconazole in treatment of denture stomatitis: comparison with itraconazole capsules.
    Cross LJ; Bagg J; Aitchison TC
    Antimicrob Agents Chemother; 2000 Feb; 44(2):425-7. PubMed ID: 10639376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward Successful Cyclodextrin Based Solubility-Enabling Formulations for Oral Delivery of Lipophilic Drugs: Solubility-Permeability Trade-Off, Biorelevant Dissolution, and the Unstirred Water Layer.
    Fine-Shamir N; Beig A; Zur M; Lindley D; Miller JM; Dahan A
    Mol Pharm; 2017 Jun; 14(6):2138-2146. PubMed ID: 28505451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclodextrins in topical drug formulations: theory and practice.
    Loftsson T; Masson M
    Int J Pharm; 2001 Aug; 225(1-2):15-30. PubMed ID: 11489551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal behavior of itraconazole in humans - Part 2: The effect of intraluminal dilution on the performance of a cyclodextrin-based solution.
    Berben P; Mols R; Brouwers J; Tack J; Augustijns P
    Int J Pharm; 2017 Jun; 526(1-2):235-243. PubMed ID: 28450167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.
    Sahbaz Y; Williams HD; Nguyen TH; Saunders J; Ford L; Charman SA; Scammells PJ; Porter CJ
    Mol Pharm; 2015 Jun; 12(6):1980-91. PubMed ID: 25905624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption.
    Hong JY; Kim JK; Song YK; Park JS; Kim CK
    J Control Release; 2006 Jan; 110(2):332-338. PubMed ID: 16297483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mucoadhesive, cyclodextrin-based vaginal cream formulation of itraconazole.
    Francois M; Snoeckx E; Putteman P; Wouters F; De Proost E; Delaet U; Peeters J; Brewster ME
    AAPS PharmSci; 2003; 5(1):E5. PubMed ID: 12713277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.